This HTML5 document contains 145 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n7http://dx.doi.org/10.1177/
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q42266414
rdf:type
wikibase:Item
schema:description
2013年論文 vitskapeleg artikkel vedecký článok scienca artikolo 2013年论文 tudományos cikk مقالة علمية نشرت في 26 سبتمبر 2013 artigo científico videnskabelig artikel wetenschappelijk artikel научни чланак articolo scientifico επιστημονικό άρθρο bài báo khoa học 2013年論文 2013年论文 artikull shkencor vitenskapelig artikkel article scientifique scientific article published on 26 September 2013 научна статия 2013年论文 tieteellinen artikkeli article científic 2013 nî lūn-bûn naučni članak teaduslik artikkel บทความทางวิทยาศาสตร์ artykuł naukowy 2013年の論文 artigo científico 2013年論文 artículo científico publicado en 2013 2013年论文 vědecký článek ২৬ সেপ্টেম্বর ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ article scientific научни чланак scientific article published on 26 September 2013 wissenschaftlicher Artikel artikulong pang-agham 2013年论文 2013년 논문 наукова стаття, опублікована у вересні 2013 научная статья מאמר מדעי articol științific bilimsel makale artikel ilmiah vetenskaplig artikel artículu científicu espublizáu en 2013 artigo científico 2013年論文 2013年论文 мақолаи илмӣ scientific article published on 26 September 2013 სამეცნიერო სტატია 2013年論文
p:P577
wds:Q42266414-46D5C262-27FC-4D05-8ADC-93B50452A334
wdt:P577
2013-09-26T00:00:00Z
p:P2860
wds:Q42266414-5D43BDA6-98C3-4C95-922D-8C656249F812 wds:Q42266414-5FC4B3C9-4611-4ACC-BDCD-3B289A22D4E2 wds:Q42266414-73889379-8486-4CA0-8B9B-CFF9C83F129F wds:Q42266414-21EB0B7E-7E82-49CA-82D8-DF275CEC6DCE wds:Q42266414-40017DAB-DBAF-4F70-B672-00AAD2AC9327 wds:Q42266414-44AEA3EE-76F6-4AA5-AE69-274E4301C7FA wds:Q42266414-4B17F52C-6C87-417E-89CE-62B933443C9B wds:Q42266414-149B6ED6-93EB-408A-B34F-A13BAF5D2F1B wds:Q42266414-FAC94821-AB5C-4F6D-8587-CAC2F7C46B95 wds:Q42266414-D4EA00D8-C1BF-4ED7-BD01-537214FF829E wds:Q42266414-DA7EE13E-48D1-4619-A349-0AC251B19E48 wds:Q42266414-DB93772A-78AE-4024-B7FE-E290A6EDB414 wds:Q42266414-E53A0BAA-714B-44F7-8A02-BB661928320C wds:Q42266414-EC670B69-CFA6-4ED6-A5E4-39CD90AB6176 wds:Q42266414-A946CA56-79D6-46CE-BC25-4DBB42D2EC64 wds:Q42266414-ABB71FF6-4EAA-42A9-9DB1-4C20B9C98909
wdt:P2860
wd:Q34275329 wd:Q37267644 wd:Q34743580 wd:Q43471219 wd:Q48873793 wd:Q45222914 wd:Q44228231 wd:Q44531075 wd:Q35194420 wd:Q39605793 wd:Q28256960 wd:Q45361114 wd:Q36508862 wd:Q48404263 wd:Q42648662 wd:Q37965603
p:P2093
wds:Q42266414-05E6DA9E-2940-4983-9813-063A4DFB3D6E wds:Q42266414-055E3480-9334-431E-B5C2-FC32EB5A0B44 wds:Q42266414-30DC8B00-2934-4CDB-97C9-CC99F9C844BD wds:Q42266414-A0757EBB-A1D6-4D62-8B8B-69E605EDA92D
wdt:P2093
Ana Etxeberria Marie-Céline Fleury Julia Salleron Marianne Giroux
rdfs:label
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab. JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
skos:prefLabel
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab. JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
schema:name
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab. JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.
p:P50
wds:Q42266414-0685AA76-E9AE-4BB0-B09C-37DCC95B4865 wds:Q42266414-0D4B750B-C99C-4E4C-81EB-499596575E1B wds:Q42266414-7A30D12F-4AEC-4910-BD10-E8566E2F34D5 wds:Q42266414-53708820-56A3-4D18-8A43-BE46B41612DF wds:Q42266414-80E533CD-7E63-48A0-AECA-CE62DFA98DEE wds:Q42266414-EBB079BB-4616-4EF9-B286-87FBBCFCE24C wds:Q42266414-EC2A1288-FE8A-4A26-A99C-276F382FDEBE wds:Q42266414-F0CCE733-84E6-4C35-8F23-80C6C224A06C
wdt:P50
wd:Q59710500 wd:Q114339931 wd:Q64095683 wd:Q114436257 wd:Q55233961 wd:Q58429863 wd:Q48384757 wd:Q95336717
p:P1476
wds:Q42266414-2BA5A4A6-9117-4986-BC9C-0368ED8ACCFB
wdt:P1476
JC-virus seroconversion in multiple sclerosis patients receiving natalizumab
p:P304
wds:Q42266414-C601CA3A-F910-4969-B3BB-C1BA8DFD6BC3
wdt:P304
822-829
p:P31
wds:Q42266414-8C0A9DB3-CDCA-437F-9506-A76A22E9B425
wdt:P31
wd:Q13442814
p:P921
wds:Q42266414-6C2B704A-AB75-4614-B8E9-746C56C15EF7 wds:Q42266414-543AC9A4-252F-4DCF-998F-5AB875D6764B
wdt:P921
wd:Q2141450 wd:Q8277
p:P698
wds:Q42266414-7BD7BED8-5599-49DD-BF3C-0C72E1AB7F8F
wdtn:P698
n10:24072722
wdt:P698
24072722
p:P1433
wds:Q42266414-2A6EAD2B-6ECE-4E1B-AE68-E886B1C0BC0C
wdt:P1433
wd:Q1952449
p:P433
wds:Q42266414-9BB7C3F1-5580-4FDE-8EF6-B25BCF196AC9
p:P478
wds:Q42266414-87E48516-D267-4388-A17C-71CC9E943371
wdt:P433
7
wdt:P478
20
p:P356
wds:Q42266414-5E6C7C17-F245-4AEB-8EDE-8BA0D14EAE26
wdtn:P356
n7:1352458513505353
wdt:P356
10.1177/1352458513505353